Literature DB >> 29853596

Answering patient-centred questions efficiently: response-adaptive platform trials in primary care.

Christopher C Butler1, Jason T Connor2, Roger J Lewis3, Kristine Broglio4, Benjamin R Saville5, Johanna Cook1, Alike van der Velden6, Theo Verheij6.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29853596      PMCID： PMC6002006          DOI： 10.3399/bjgp18X696569

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  8 in total

Review 1.  Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2.

Authors:  Brian M Alexander; Patrick Y Wen; Lorenzo Trippa; David A Reardon; Wai-Kwan Alfred Yung; Giovanni Parmigiani; Donald A Berry
Journal:  Neuro Oncol       Date:  2013-07-14       Impact factor: 12.300

2.  Are outcome-adaptive allocation trials ethical?

Authors:  Spencer Phillips Hey; Jonathan Kimmelman
Journal:  Clin Trials       Date:  2015-02-03       Impact factor: 2.486

3.  Efficiencies of platform clinical trials: A vision of the future.

Authors:  Benjamin R Saville; Scott M Berry
Journal:  Clin Trials       Date:  2016-02-17       Impact factor: 2.486

Review 4.  Evidence-based medicine and general practice.

Authors:  L D Jacobson; A G Edwards; S K Granier; C C Butler
Journal:  Br J Gen Pract       Date:  1997-07       Impact factor: 5.386

5.  The platform trial: an efficient strategy for evaluating multiple treatments.

Authors:  Scott M Berry; Jason T Connor; Roger J Lewis
Journal:  JAMA       Date:  2015-04-28       Impact factor: 56.272

6.  Lung Master Protocol (Lung-MAP)-A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400.

Authors:  Roy S Herbst; David R Gandara; Fred R Hirsch; Mary W Redman; Michael LeBlanc; Philip C Mack; Lawrence H Schwartz; Everett Vokes; Suresh S Ramalingam; Jeffrey D Bradley; Dana Sparks; Yang Zhou; Crystal Miwa; Vincent A Miller; Roman Yelensky; Yali Li; Jeff D Allen; Ellen V Sigal; David Wholley; Caroline C Sigman; Gideon M Blumenthal; Shakun Malik; Gary J Kelloff; Jeffrey S Abrams; Charles D Blanke; Vassiliki A Papadimitrakopoulou
Journal:  Clin Cancer Res       Date:  2015-02-13       Impact factor: 12.531

7.  Bayesian adaptive trials offer advantages in comparative effectiveness trials: an example in status epilepticus.

Authors:  Jason T Connor; Jordan J Elm; Kristine R Broglio
Journal:  J Clin Epidemiol       Date:  2013-08       Impact factor: 6.437

8.  Do Bayesian adaptive trials offer advantages for comparative effectiveness research? Protocol for the RE-ADAPT study.

Authors:  Jason T Connor; Bryan R Luce; Kristine R Broglio; K Jack Ishak; C Daniel Mullins; David J Vanness; Rachael Fleurence; Elijah Saunders; Barry R Davis
Journal:  Clin Trials       Date:  2013-08-27       Impact factor: 2.486
  8 in total
  4 in total

1.  Point-of-Care Clinical Trials in Sports Medicine Research: Identifying Effective Treatment Interventions Through Comparative Effectiveness Research.

Authors:  Kenneth C Lam; Cailee E Welch Bacon; Eric L Sauers; R Curtis Bay
Journal:  J Athl Train       Date:  2019-10-16       Impact factor: 2.860

2.  Optimising trial designs to identify appropriate antibiotic treatment durations.

Authors:  Koen B Pouwels; Mo Yin; Christopher C Butler; Ben S Cooper; Sarah Wordsworth; A Sarah Walker; Julie V Robotham
Journal:  BMC Med       Date:  2019-06-21       Impact factor: 8.775

3.  Reporting of master protocols towards a standardized approach: A systematic review.

Authors:  Ellie G Siden; Jay Jh Park; Michael J Zoratti; Louis Dron; Ofir Harari; Kristian Thorlund; Edward J Mills
Journal:  Contemp Clin Trials Commun       Date:  2019-07-04

4.  Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk.

Authors:  Gail Hayward; Christopher C Butler; Ly-Mee Yu; Benjamin R Saville; Nicholas Berry; Jienchi Dorward; Oghenekome Gbinigie; Oliver van Hecke; Emma Ogburn; Hannah Swayze; Emily Bongard; Julie Allen; Sharon Tonner; Heather Rutter; Sarah Tonkin-Crine; Aleksandra Borek; David Judge; Jenna Grabey; Simon de Lusignan; Nicholas P B Thomas; Philip H Evans; Monique I Andersson; Martin Llewelyn; Mahendra Patel; Susan Hopkins; F D Richard Hobbs
Journal:  BMJ Open       Date:  2021-06-18       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.